Can Prednisolone (Pediapred) Be Given to Infants with COVID-19?
Yes, prednisolone can be given to infants with COVID-19, but only in specific clinical scenarios: primarily for Multisystem Inflammatory Syndrome in Children (MIS-C) or severe COVID-19 requiring oxygen support—not for mild or moderate acute COVID-19 infection.
Clinical Context Determines Use
The decision to use prednisolone in infants with COVID-19 depends entirely on the clinical presentation:
When Prednisolone IS Indicated:
MIS-C (Most Common Indication):
- If the infant meets MIS-C criteria (persistent fever ≥38.5°C, multiorgan involvement, elevated inflammatory markers, and evidence of SARS-CoV-2 exposure), prednisolone is a first-line treatment 1
- Dosing for MIS-C: Methylprednisolone 1-2 mg/kg/day IV (or equivalent prednisolone dose) alongside IVIG 2 gm/kg 1
- For refractory MIS-C with persistent fever or significant organ involvement, escalate to methylprednisolone 10-30 mg/kg/day 1
Severe Acute COVID-19:
- Corticosteroids are recommended for children and adolescents with severe to critical COVID-19 requiring supplemental oxygen or mechanical ventilation 2, 3
- This applies to infants who develop significant respiratory compromise with hypoxemia
When Prednisolone is NOT Indicated:
Mild to Moderate COVID-19:
- Corticosteroids are NOT recommended in children and adolescents with mild to moderate COVID-19 who do not require oxygen 2
- Recent evidence shows no benefit in preventing long COVID in outpatient children treated with steroids during acute infection 4
Practical Dosing Guidance
The FDA label for Pediapred provides flexibility 5:
- Pediatric dosing range: 0.14 to 2 mg/kg/day in 3-4 divided doses (4-60 mg/m²/day)
- Specific to clinical severity: Lower doses for less severe conditions; higher initial doses for critical illness
- Dosing must be individualized based on disease severity and response
For an infant (typically <1 year, weight 5-10 kg):
- MIS-C: Start with 1-2 mg/kg/day (5-20 mg/day total) divided into doses
- Severe COVID-19 pneumonia: Similar dosing as MIS-C protocol
Safety Considerations in Infants
Important caveats when using prednisolone in infants:
- Monitor growth velocity closely - corticosteroids can suppress growth even at low doses and without HPA axis suppression 5
- Titrate to lowest effective dose to minimize growth effects 5
- Watch for infections - corticosteroids may suppress immune response to vaccines and increase infection risk 5
- Avoid abrupt discontinuation - taper gradually after long-term use 5
- Case reports support safety - prednisolone has been used successfully in infants as young as 2 months for COVID-19-related complications without adverse events 6, 7
Evidence Quality Assessment
The recommendations are based on:
- Strong guideline evidence from the American College of Rheumatology for MIS-C treatment 1
- Moderate evidence from international pediatric guidelines supporting corticosteroids only in severe COVID-19 2, 3
- Emerging evidence suggesting no benefit (and possible harm with high doses) in mild-moderate disease 4, 8
Clinical Algorithm
Assess disease severity:
- Mild/moderate (no oxygen need) → NO corticosteroids
- Severe (oxygen requirement) → Consider corticosteroids
- MIS-C criteria met → Corticosteroids indicated
If corticosteroids indicated:
- Start methylprednisolone 1-2 mg/kg/day IV or equivalent oral prednisolone
- Combine with IVIG if MIS-C
- Monitor inflammatory markers, cardiac function, and clinical response
Escalate if refractory:
- Persistent fever or worsening organ function → increase to 10-30 mg/kg/day
- Consider additional immunomodulators (anakinra) 1
Common Pitfalls to Avoid
- Do not use corticosteroids prophylactically in asymptomatic or mildly symptomatic COVID-19-positive infants
- Do not use high-dose pulse steroids empirically - associated with increased mortality in ICU patients 8
- Do not forget eye protection if facial nerve involvement (as in Bell's palsy case) 6
- Do not stop abruptly - always taper to prevent adrenal insufficiency 5